Analgesic and Anti-Inflammatory Effects of Acetylsalicylic Acid: Physiological Mechanisms

Abstract

1. Vejn A. M., Pain syndromes in neurological practice, 368 p. (Moscow, MED-press-inform, 2001). 2. Vengerovskij A. I., Lectures on Pharmacology, 390 p. (Tomsk, SibGMU, 2007). 3. Sapegin I. D., Basic pharmacology, 122 p. (KSMU, Simferopol, 2012). 4. Vertkin A. L., Naumov A. V., Shamuilova M. M., Ivanov V. S., Sugaipov A. A., Otpushenko A. A., Dilemma of choice of non-steroidal anti-inflammatory drugs in therapeutic practice, Klinicist, 8, 2, 46 (2008). 5. Katyushina O. V., Cheretaev I. V., Berezhnev L. Yu., Shilina V. V., Husainov D. R., Gamma T. V., The severity of antidepressant and analgesic effects of aspirin and its derivatives in a wide range of doses, 77th final scientific-practical conference with international participation, Krasnoyarsk, 23-26 April 2013, pp. 427-429 (Krasnoyarsk, KrasGMU-Verso, 2013). 6. Katyushina O. V., Mechanisms of the physiological effect of ultrasmall doses of aspirin and its derivatives, 150 p. (Simferopol, TNU, 2013). 7. Mashkovskij M. D., Medicines of the ХХ century, 320 p. (Izdatel'stvo Novaya Volna, Moscow, 1998). 8. Dejl M. M., Formen K., Guidelines for Immunopharmacology, (Moscow, Medicina, 1998). 9. Mashkovskij M. D., Acetilsalicilovaya kislota v ryadu sovremennyh lekarstvennyh sredstv, Him.-farm. zhurn., 28, 2, 4 (1994). 10. Mashkovskij M. D., Lekarstvennye sredstva: v 2 t., 1, 540 p. (Moscow, Izdatel'stvo Novaya Volna, 2002). 11. Osipova N. A., Abuzarova G. R., Petrova V. V., Principles of using analgesics for acute and chronic pain, 67 p. (Moscow, MNIOI, 2010). 12. Kovalenko V. N., Viktorov A. P., Compendium - 2005 – drugs, 1920 p. (Kiev, Morion, 2005). 13. Katyushina O. V., Yakovchuk T. V., Korenyuk I. I., Husainov D. R., Gamma T. V., Cheretaev I. V., Effect of Ultra-low Doses Aspirin, Acetylsalicylate Cobalt and Zinc on Pain Sensitivity Rats, Uspekhi sovremennogo estestvoznaniya, 9, 28 (2012). 14. Katyushina O. V., Shilina V. V., Korenyuk I. I., Gamma T. V., Cheretaev I. V., Changing the pain threshold under the action of aspirin and analgin in standard and ultra-low doses, Wpływ badań naukowych: zbiór raportów naukowych Miedzynarodowej Naukowi-Praktycznej Konferencji, Bydgoszcz (28.04-30.04.2013), 1, 71 (Warszawa, Diamond trading tour, 2013). 15. Katyushina O. V., Cheretaev I. V., Husainov D. R., Gamma T. V., Analgesic effect of ultra-low doses of aspirin and its salts on the background of D2-receptor blockade, Vestnik Permskoj gosudarstvennoj farmacevticheskoj akademii, 1, 10, 59 (2013). 16. Katyushina O. V., Korenyuk I. I., Husainov D. R., Gamma T. V., Cheretaev I. V., Shul'gin V. F., Analgesic effect of ultra-low doses of aspirin against the background of oppression and stimulation of the dopaminergic system, Proceedings of the IX international scientific and technical conference "Actual problems of biological physics and chemistry – 2013", April 23-27, 2013, 141 (SevNTU, Sevastopol', 2013). 17. Katyushina O. V., Husainov D. R., Korenyuk I. I., Gamma T. V., Cheretaev I. V., Kolotilova O. I., Anti-inflammatory activity of acetylsalicylic acid and its salts, X Mіzhnarodnі Novorіchnі bіologіchnі chitannya, 10, 186 (2010). 18. Benedito M. A., Gender differences in the activities of aspirin-esterases in rat tissues, Braz. J. Med. Biol. Res., 31, 9, 1113 (1998). 19. Colby H. D., Regulation of hepatic drug and steroid metabolism by androgens and estrogens, Advances in Sex Hormone Research, J. A. Thomas, R. L. Signal eds., 4, 27 (Baltimore, Urban and Schwartzenberg, 1980). 20. Gustafsson J. A., Mode A., Norstedt G., Skett P., Sex steroid induced changes in hepatic enzymes, Annual Review of Physiology, 45, 51 (1983). 21. Kennedy M. J., Hormonal regulation of hepatic drug-metabolizing enzyme activity during adolescence, Clinical Pharmacology and Therapeutics, 84, 6, 662 (2008). 22. Miners J. O., Grgurinovich N., Whitehead A. G., Robson R. A., Birkett D. J., Influence of gender and oral contraceptive steroids on the metabolism of salicylic acid and acetylsalicylic acid, Br. J. Clin. Pharmacol., 22, 2, 135 (1986). 23. Menguy R., Desbaillets L., Masters Y. F., Okabe S., Evidence for a sex-linked difference in aspirin metabolism, Nature, 239, 5367, 102 (1972). 24. Kim D., Yang Y., Jakoby W. B., Aspirin hydrolyzing esterases from rat liver cytosol, Biochem. Pharmacol., 40, 3, 481 (1990). 25. Tamargo J., Rosano G., Walther T., Duarte J., Niessner A., Kaski J. C., Ceconi C., Drexel H., Kjeldsen K., Savarese G., Torp-Pedersen C., Atar D., Lewis B. S., Agewall S., Gender differences in the effects of cardiovascular drugs, European Heart Journal - Cardiovascular Pharmacotherapy, 3, 163 (2017). 26. Berger J. S., Roncaglioni M. C., Avanzini F., Pangrazzi I., Tognoni G., Brown D. L., Aspirin for the primary prevention of cardiovascular events in women and men: a sex-specific meta-analysis of randomized controlled trials, JAMA, 295, 3, 306 (2006). 27. Cavallari L. H., Helgason C. M., Brace L. D., Viana M. A., Nutescu E. A., Sex difference in the antiplatelet effect of aspirin in patients with stroke, Ann. Pharmacother., 40, 5, 812 (2006). 28. Richardson J., Holdcroft A., Gender differences and pain medication, Women's Health, 5, 1, 79 (2009). 29. Yin M. J., Yamamoto Y., Gaynor R. B., The anti-inflammatory agents aspirin and salicylate inhibit the activity of I(kappa)B kinase-beta, Nature, 396, 6706, 77 (1998). 30. Grilli M., Pizzi M., Memo M., Spano P., Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappa B activation, Science, 274, 5291, 1383 (1996). 31. Kolpakova A. F., Sharipov R. N., Latysheva A. N., Kolpakov F. A., Transkripcionnyj faktor NF-κB igraet klyuchevuyu rol' v regulyacii genov, uchastvuyushchih v vospalitel'nyh i immunnyh reakciyah, Sibirskoe medicinskoe obozrenie, 3 (57), 7 (2009). 32. Ragulina V. A., Kostina D. A., Dovgan A. P., Burda Y. E., Nadezhdin S. V., Nuclear factor kappa B as a potential target for pharmacological correction endothelium-associated pathology, Research result: pharmacology and clinical pharmacology, 3, 1, 114 (2017). 33. D'Acquisto F., May M. J., Ghosh S., Inhibition of nuclear factor kappa B (NF-B): an emerging theme in anti-inflammatory therapies, Mol. Interv., 2, 1, 22 (2002). 34. Yoo C. G., Lee S., Lee C. T., Kim Y. W., Han S. K., Shim Y. S., Effect of acetylsalicylic acid on endogenous I kappa B kinase activity in lung epithelial cells, Am. J. Physiol. Lung. Cell. Mol. Physiol., 280, 1, 3 (2001). 35. Muller D. N., Heissmeyer V., Dechend R., Hampich F., Park J. K., Fiebeler A., Shagdarsuren E., Theuer J., Elger M., Pilz B., Breu V., Schroer K., Ganten D., Dietz R., Haller H., Scheidereit C., Luft F. C., Aspirin inhibits NF-kappaB and protects from angiotensin II-induced organ damage, FASEB J., 15, 10, 1822 (2001). 36. Vane J. R., Botting R. M., The mechanism of action of aspirin, Thrombosis Research, 110, 5-6, 255 (2003). 37. Vane J. R., Bakhle Y. S., Botting R. M., Cyclooxygenases 1 and 2, Annu. Rev. Pharmacol. Toxicol., 38, 97 (1998). 38. Blobaum A. L., Marnett L. J., Structural and Functional Basis of Cyclooxygenase Inhibition, J. Med. Chem. 50, 7, 1425 (2007). 39. Rouzer C. A., Marnett L. J., Cyclooxygenases: structural and functional insights, J. Lipid Res., 50, 29 (2009). 40. Timoshchuk O. V., Lembrik I. S., Kocherga Z. R., Prostaglandiny – universal'nye bioregulyatory v organizme cheloveka (obzor literatury), Zaporozhskij medicinskij zhurnal, 20, 1 (106), 121 (2018). 41. Pinckard R. N., Hawkins D., Farr R. S., In vitro acetylation of plasma proteins, enzymes and DNA by aspirin, Nature, 219, 5149, 68 (1968). 42. Rainsford K. D., Shweitzer A., Brune K., Distribution of the acetyl compared with the salicyl moiety of acetylsalicylic acid. Acetylation of macromolecules in organs wherein side-effects are manifest, Biochem. Pharmacol., 32, 7, 1301 (1983). 43. Alfonso L. F., Srivenugopal K. S., Bhat G. J., Does aspirin acetylate multiple cellular proteins? (Review), Mol. Med. Rep., 2, 4, 533 (2009). 44. Bjornsson T. D., Schneider D. E., Berger H. J., Aspirin acetylates fibrinogen and enhances fibrinolysis. Fibrinolytic effect is independent of changes in plasminogen activator levels, J. Pharmacol. Exp. Ther., 250, 1, 154 (1989). 45. Alfonso L. F., Srivenugopal K. S., Arumugam T. V., Abbruscato T. J., Weidanz J. A., Bhat G. J., Aspirin inhibits camptothecin-induced p21CIP1 levels and potentiates apoptosis in human breast cancer cells, Int. J. Oncol., 34, 3, 597 (2009). 46. Honma K., Nakamura M., Ishikawa Y., Acetylsalicylate-human serum albumin interaction as studied by NMR spectroscopy – antigenicity-producing mechanism of acetylsalicylic acid, Mol. Immunol., 28, 1-2, 107 (1991). 47. Cheretaev I. V., Features of electric potentials of Helix albescens Rossm. mollusss neurons at the action of standard and newly synthesized salicylates, 142 p. (Simferopol, TNU, 2012). 48. Karymova E. A., Ionnye mekhanizmy kodirovaniya nociceptivnyh signalov: rol' medlennyh natrievyh kanalov, 18 s. (SPb., 2009). 49. Cheretaev I. V., Khusainov D. R., Koreniuk I. I., Chuyan E. N., Ravaeva M. Yu., Shulgin V. F., Gusev A. N., Neurotropic effects of salicylates: physiological mechanisms, Scientific Notes of V. I. Vernadsky Crimean Federal University. Biology. Chemistry., 5 (71), 4, 201 (2019). 50. Zefirov A. L., Sitdikova G. F., Ionnye kanaly nervnogo okonchaniya, Uspekhi fiziol. Nauk, 33, 4, 3 (2002). 51. Kamkin A. G., Kiselyova I. S., Fiziologiya i molekulyarnaya biologiya membran kletok, 592 p. (Akademiya, Moskva, 2008). 52. Kostyuk P. G., Bіofіzika klіtini yak osnova suchasnoї farmakoterapії, Zhurn. AMN Ukraini, 10, 1, 220 (2004). 53. Shuba YA. M., Osnovi molekulyarnoї fіzіologії іonnih kanalіv, 448 p. (Kiev, Naukova dumka, 2010). 54. Cheretaev I. V., Korenyuk I. I., Husainov D. R., Chajka A. V., Vliyanie acetilsalicilovoj kisloty na elektricheskuyu aktivnost' nejronov PPa1 I PPa2 mollyuska Helix albescens Rossm., Molodoj uchyonyj, 20 (100), 106 (2015). 55. Vislobokov A. I., Ignatov Yu. D., Sovremennye predstavleniya o vozdejstvii farmakologicheskih sredstv na ionnye kanaly, Psihofarmakol. biol. narkol., 7, 3-4, 2121 (2007). 56. Darbinyan T. M., Golovchinskij V. B., Mekhanizmy narkoza, 264 p. (Moskva, Medicina, 1972). 57. Hille B., Ionic channels of excitable membranes, 722 p. (University of Washington, 2001). 58. Cheretaev I. V., Husainov D. R., Yakovlev A. V., Sitdikova G. F., Korenyuk I. I., Vliyanie neopiodnogo anal'getika «Aspirin» na GAMK-obuslovlennuyu setevuyu aktivnost' nejronov gippokampa novorozhdyonnyh krysyat, Tez. dokl. XII Mezhdunarodnoj krymskoj konferencii Kosmos i biosfera, 205 (Simferopol, IT ARIAL, 2017). 59. Cheretaev I. V., Husainov D. R., Yakovlev A. V., Sitdikova G. F., GAMK-obuslovlennaya setevaya aktivnost' nejronov gippokampa krysyat pod vliyaniem razlichnyh koncentracij aspirina, Materialy XXIII s"ezda Fiziologicheskogo obshchestva imeni I. P. Pavlova, 2020 (Voronezh, Istoki, 2017). 60. Cheretaev I. V., Husainov D. R., Korenyuk I. I., Aspirin aktiviruet i sinhroniziruet spontannye GAMK-obuslovlennye setevye otvety nejronov gippokampa novorozhdyonnyh krysyat, IV nauchno-prakticheskaya konferenciya professorsko-prepodavatel'skogo sostava, aspirantov, studentov i molodyh uchenyh «Dni nauki KFU im. V.I. Vernadskogo» abstr., 2, 1212 (Simferopol, TA, 2018). 61. Husainov D. R., Yakovlev A. V., Sitdikova G. F., Cheretaev I. V., Chajka A. V., Halikova E. V., Dinamika kalievyh tokov nejronov krysyat i ulitok pri dejstvii aspirina, Nejronauka dlya mediciny i psihologii: 13-j Mezhdunarodnyj mezhdisciplinarnyj kongress. Sudak, Krym, Rossiya 30.05–10.06.2017, 437 (Moskva, MAKS Press, 2017). 62. Nikitin V. P., Sherstnyov V. V., Prostaglandiny i funkcional'naya specifichnost' nejronov vinogradnoj ulitki, Nejrofiziologiya/Neurophysiology, 13, 6, 580 (1981). 63. Karelov A. E., Zaharov D. A., Lebedinskij K. M., Semyonov D. A., Novye tekhnologii v anesteziologii: purinovaya analgeziya, Vestnik SPbSU. Medicine, 1, S., 77 (2008). 64. Cheretaev I. V., Korenyuk I. I., Husainov D. R., Katyushina O. V., Gamma T. V., Kolotilova O. I., Analysis of ATP-dependent and calcium mechanisms in the neurotropic effect of aspirin and its derivatives, Uspekhi sovremennogo estestvoznaniya, 4, 64 (2013). 65. Cheretayev I. V., Korenyuk I. I., Shulgin V. F., Husainov D. R., Katyushina O. V., Kolotilova O. I., Adenosinetriphosphate- and calciumdependenсe mechanisms of salicylate neurotropic effects, Scientific Notes of Taurida V. Vernadsky National University. Series: Biology, chemistry, 25 (64), 1, 230 (2012). 66. Cheretaev I. V., Korenyuk I. I., Husainov D. R., Gamma T. V., Kolotilova O. I., Nozdrachyov A. D. ATP- and calcium-dependent mechanisms of salicylates influence on electric potentials of neurons in mollusk Helix albescens, Rossijskij fiziologicheskij zhurnal im. I. M. Sechenova, 101, 3, 326 (2015). 67. Сheretaev I. V., Korenyuk I. I., Khusainov D. R., Gamma T. V., Kolotilova O. I., Nozdrachev A. D., ATP-Dependent and Calcium Mechanisms of the Effects of Salicylates on Electrical Potentials in Neurons in the Mollusk Helix Albescens, Neuroscience and Behavioral Physiology, 46, 6, 644 (2016). 68. Kruteckaya Z. I., Kurilova L. S., Antonov V. G., Nozdrachyov A. D., Ingibitory ciklooksigenaz i lipoksigenaz moduliruyut effekt glutoksima i moliksana na vnutrikletochnuyu koncentraciyu Ca2+ v makrofagah, Doklady Akademii Nauk, 452, 6, 690 (2013). 69. Kurilova L. S., Kruteckaya Z. I., Naumova A. A., Butov S. N., Kruteckaya N. I., Antonov V. G., Vliyanie ingibitorov ciklooksigenaz i lipoksigenaz na Ca2+-otvety, vyzyvaemye glutoksimom i moliksanom, v makrofagah, Citologiya, 56, 5, 353 (2014). 70. Kokoska E. R., Smith G. S., Wolff A. B., Miller T. A., Nonsteroidal anti-inflammatory drugs attenuate epidermal growth factor-induced proliferation independent of prostaglandin synthesis ingibition, J. Surg. Res., 84, 2, 186 (1999). 71. Kokoska E. R., Smith G. S., Miller T. A., Store-operated calcium influx in human gastric cells: Role of endogenous prostaglandins, Surgery, 124, 2, 429 (1998). 72. Veld B. A., Ruitenberg A., Hofman A., Launer L. J., van Duijn C. M., Stijnen T., Breteler M. M., Stricker B.H., Nonsteroidal antiinflammatory drugs and the risk of the Alzheimer's disease, N. Engl. J. Med., 345, 21, 1515 (2001) 73. Besprozvannyj I. B., System of calcium signaling during neurodegeneration, Acta Naturae, 2, 1, 80 (2010). 74. Vojtenko N. V., Kostyuk E. P., Kostyuk P. G., Bolevye sindromy i vnutrikletochnaya kal'cievaya signalizaciya, Trudy MFTI, 1, 1, 17 (2009). 75. Husainov D. R., Cheretaev I. V., Katyushina O. V., Korenyuk I. I., Gamma T. V., Kolotilova O. I. The effect of acetylsalicylic acid and its salts on synaptic retention in the subpharyngeal ganglia of a snail, Tavricheskij mediko-biologicheskij vestnik, 14, 4 (2) 171 (2011). 76. Ekkls Dzh., Fiziologiya sinapsov, 395 p. (Moskva, Mir, 1966). 77. Meir A., Ginsburg S., Butkevich A., Kachalsky S. G., Kaiserman I., Ahdut R., Demirgoren S., Rahamimoff R., Ion channels in presinaptic nerve terminals and control of transmitter realease, Physiol. Rev., 79, 3, 1019 (1999). 78. Dilger J. P., The effects of general anaesthetics on ligand-gated ion channels, Br. J. Anaesth., 89, 1, 41 (2002). 79. Scholz A., Mechanisms of (local) anaesthetics on voltage-gated sodium and other ion channels, Br. J. Anaesth., 89, 1, 52 (2002). 80. Husainov D. R., Temur'yanc N. A., Tumanyanc K. N., Peculiarities of analgesic activity of aspirin in female rats under conditions of moderate electromagnetic shielding, Scientific Notes of V. I. Vernadsky Crimean Federal University. Biology. Chemistry., 1 (67), 3, 56 (2015). 81. Husainov D. R., Temur'yanc N. A., Korenyuk I. I., Cheretaev I. V., Chajka A. V., Tumanyanc K. N. Moderate electromagnetic shielding of rats neutralizes the analgesic effect of aspirin, Mezhdunarodnyj zhurnal prikladnyh i fundamental'nyh issledovanij, 7, 76 (2015). 82. Temur'yanc N. A., Kostyuk A. S., The role of the opioid system in modulating the thermonociceptive sensitivity of mollusks under the action of weak electromagnetic factors, Nejrofiziologiya/Neurophysiology, 43, 5, 432 (2011). 83. Temur'yanc N. A., Kostyuk A. S., Participation of melatonin in change of nociception of snails and mice under influence of long-term electromagnetic shielding, Rossijskij fiziologicheskij zhurnal im. I.M. Sechenova, 99, 11, 1333 (2013). 84. Husainov D. R., Shylina V. V., Korenyuk І. І., Shulgin V. F., Modifying action of heavy metal salts on anti-inflammatory aspirin action, Health, 2, 6, 630 (2010). 85. Shilina V. V., Husainov D. R., Cheretaev I. V., Korenyuk I. I., Analgesic Effect of Aspirin Against a Background of Heavy Metal Salts Intoxication and After Blocking D2-receptors, Scientific Notes of Taurida V. I. Vernadsky National University. Series: Biology, chemistry., 27 (66), 1, 232 (2014).